Skip to main content
. 2021 Jun;16(6):870–879. doi: 10.2215/CJN.15751020

Table 3.

Associations of smoking cessation duration and cumulative smoking dose with prevalent coronary artery calcification in former smokers

Smoking History No. of Events (%) Former versus Never Smoker Former versus Current Smoker
Prevalence Ratio (95% CI) a P Value Prevalence Ratio (95% CI) a P Value
Smoking dose
 Never smoker 411/990 (42) 1.00
 Former smoker 346/592 (58)
  Group 1 (0.1 to <10 pack-yr) 785/190 (41) 0.98 (0.83 to 1.15) 0.81 0.77 (0.65 to 0.90) 0.001
  Group 2 (10 to <20 pack-yr) 75/136 (55) 1.08 (0.92 to 1.28) 0.40 0.88 (0.76 to 1.03) 0.13
  Group 3 (≥20 pack-yr) 193/266 (73) 1.13 (1.00 to 1.27) 0.05 0.95 (0.85 to 1.06) 0.40
 Current smoker 195/332 (59) 1.00
Duration of smoking cessation
 Never smoker 411/990 (42) 1.00
 Former smoker b 284/495 (57)
  Group 1 (0.5 to <10 yr) 105/190 (55) 1.19 (1.02 to 1.39) 0.02 0.96 (0.33 to 1.10) 0.56
  Group 2 (10 to <20 yr) 98/183 (54) 1.05 (0.90 to 1.22) 0.54 0.85 (0.73 to 0.98) 0.02
  Group 3 (≥20 yr) 81/122 (66) 0.99 (0.86 to 1.14) 0.9 0.83 (0.73 to 0.96) 0.01
 Current smoker 195/332 (59) 1.00

95% CI, 95% confidence interval.

a

Model was adjusted for age, sex, diabetes mellitus, economic status, educational level, body mass index, systolic BP, statin use, calcium-phosphate products, eGFR, and urinary protein-to-creatinine ratio.

b

Because of data availability for cessation duration, only 495 former smokers were analyzed.